EVNIN LUKE

CIK 000113465722 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001134657

Recent Transactions

50 trades

Other
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−4,158,964→ 0 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−4,158,964→ 0 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−4,158,964→ 0 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−4,158,964→ 0 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−4,158,964→ 0 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2023-06-01−4,158,964→ 0 total
Sale
ReShape Weightloss Inc.
Common Stock
2014-01-08$2.50/sh−284,531→ 1,113,168 total
Sale
ReShape Weightloss Inc.
Common Stock
2014-01-08$2.50/sh−284,531→ 1,113,168 total
Sale
ReShape Weightloss Inc.
Common Stock
2014-01-07$2.50/sh−190,334→ 1,397,699 total
Sale
ReShape Weightloss Inc.
Common Stock
2014-01-07$2.50/sh−190,334→ 1,397,699 total
Sale
ReShape Weightloss Inc.
Common Stock
2014-01-06$2.50/sh−81,720→ 1,588,033 total
Sale
ReShape Weightloss Inc.
Common Stock
2014-01-06$2.50/sh−81,720→ 1,588,033 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2013-05-20$30.00/sh−13,550→ 1,183,712 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2013-05-20$30.00/sh−13,550→ 1,183,712 total
Award
Pacira BioSciences, Inc.$PCRX
Director Stock Option (Right to Buy)
2011-06-02+15,692→ 15,692 total
Award
Pacira BioSciences, Inc.$PCRX
Director Stock Option (Right to Buy)
2011-06-02+15,692→ 15,692 total
Purchase
Radius Health, Inc.
Series A-3 Convertible Preferred Stock
2011-05-17+53,331→ 53,331 total
Purchase
Radius Health, Inc.
Series A-2 Convertible Preferred Stock
2011-05-17+402,115→ 402,115 total
Purchase
Radius Health, Inc.
Series A-1 Convertible Preferred Stock
2011-05-17+200,909→ 200,909 total
Disposition to Issuer
Radius Health, Inc.
Common Stock
2011-05-17$0.01/sh−5,000,000→ 0 total
Disposition to Issuer
Radius Health, Inc.
Common Stock
2011-05-17$0.01/sh−5,000,000→ 0 total
Purchase
Radius Health, Inc.
Series A-2 Convertible Preferred Stock
2011-05-17+402,115→ 402,115 total
Purchase
Radius Health, Inc.
Series A-1 Convertible Preferred Stock
2011-05-17+200,909→ 200,909 total
Purchase
Radius Health, Inc.
Series A-3 Convertible Preferred Stock
2011-05-17+53,331→ 53,331 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total
Disposition from Tender
MEMORY PHARMACEUTICALS CORP
Common Stock
2009-01-01$0.61/sh−14,138,993→ 0 total

Recent Filings

Address

C/O MPM CAPITAL 399 BOYLSTON STREET, SUITE 1100

BOSTON, MA, 02116

View on SEC.gov